medigraphic.com
ISSN 1729-519X (Print)

2013, Number 3

<< Back Next >>

Revista Habanera de Ciencias Médicas 2013; 12 (3)

Antineutrophil cytoplasmic antibodies determination for vasculitis diagnosis

Martínez TG, Ramos RMA, Torres RB, Sánchez RV, Martiato HM, Abreu PN

Language: Spanish
References: 20
Page: 446-453
PDF size: 61.41 Kb.


ABSTRACT

Introduction: antineutrophil cytoplasmic antibodies contribute to the diagnosis of systemic vasculitis.
Objective: demonstrate the diagnostic value of Antineutrophil cytoplasmic antibodies assessing by indirect immunofluorescence doing its standardization and validation.
Material and methods: standardization and validation of antineutrophil cytoplasmic antibodies determination by indirect immunofluorescence. The sample consisted of 20 patients with systemic vasculitis, 45 with rheumatic diseases and 24 healthy individuals.
Results and Discussion: the sensitivity, specificity, and predictive values were adequate. Good method performance and good agreement was obtained with the reference tests. These antibodies were present in patients with vasculitis (54%), rheumatoid arthritis (19%) and systemic lupus erythematosus (37%).
Conclusions: the developed method has a great diagnostic usefulness and can be applied in the study of systemic vasculitis, finding a good match between the patterns and antigenic specificities.


REFERENCES

  1. Watts RA, Scott DG. Recent developments in the classification and assessment of vasculitis. Best Pract Res Clin Rheumatol. 2009; 23(3):429-43.

  2. Charles J, Falk RJ. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Current Opinion in Rheumatology. 2008; 20:5560.

  3. Talor MV, Stone JH, Stebbing J, Barin J, Rose NR, Burek CL. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Clinical and Experimental Immunology. 2007; 150:4248.

  4. Rodrigues CE, Velloso ER, Pereira RM, Bonfá E, Teixeira FK, Bueno C, et al. A novel 60 kDa reactivity in cyclic neutropenia: high titer cytoplasmic ANCA immunostaining pattern and negative anti-proteinase-3 antibody. Joint Bone Spine. 2011; 78:319-20.

  5. Khasnis A, Langford CA. Update on vasculitis. J Allergy Clin Immunol. 2009; 123(6):1226-36.

  6. Eisenberger U, Hess C. Systemic ANCA-associated vasculitis diagnosis and therapy. Ther Umsch. 2008; 65(5):295-301.

  7. Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010; 56:3-23.

  8. Holle JU, Bley T, Gross WL. Classification and therapy of vasculitis according to recommendations of the European League Against Rheumatism (EULAR) Radiologe. 2010 Oct;50(10):846-54.

  9. Atul Khasnis y Carol A. Langford. Actualización sobre vasculitis. JACI .2009; 123:1226-36.

  10. Yuksel C, Ayli MD, Yuksel A, et al. Propylthiouracil-induced vasculitis associated with ANCA: a case report. Ren Fail 2007; 29:235-237.

  11. Jennette J, Falk R, Bacon P, et al. Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2012; 65: 1-11.

  12. Kallenberg CG. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun. 2008; 30(1-2):29-36.

  13. Nakano H, Ozaki S. Review article. Antineutrophil cytoplasmic antibody in small vessel vasculitis. Rinsho Byori. 2010; 58(5):480-9.

  14. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, Davidovits A, Raab I, Jahn R, Ashour O, Spitzauer S, Sunder-Plassmann G, Fukuda M, Klemm P, Rees AJ, Kerjaschki D. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008; 14:1088-1096.

  15. Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, et al.Evaluation of Capture ELISA for the detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicenter study. Rheumatology. 2004; 43:174-80.

  16. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 19. Scand J Clinc Invest. 1968; 21 (Suppl 97): 77-89.

  17. Savige J, Gilles D, Berson E y col. International Concensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 1999; 111: 507-513.

  18. Torres B, Seguí F, Martínez G, Ochoa RF, Duany J, Rangel S. Validación de un método de inmunofluorescencia indirecta para la determinación de anticuerpos contra el músculo liso. Revista Eugenio Espejo. 2013; 5 (1): 34-46.

  19. Ochoa RF. «Validación de los inmunoensayos empleados para evaluar la inmunogenicidad de vacunas». En: Ochoa RF. Bases Metodológicas para la evaluación de anticuerpos en ensayos clínicos de vacunas mediante técnicas inmunoenzimáticas.1 ed. Ciudad de La Habana: Finlay; 2004, p. 57-78.

  20. Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. Asociación Médica Mundial: 2003-2007; 2008. Disponible en: http://www.wma.Net/S/Policy/B3.Htm.




2020     |     www.medigraphic.com